Alembic Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE901L01018
  • NSEID: APLLTD
  • BSEID: 533573
INR
898.75
-3.45 (-0.38%)
BSENSE

Dec 05

BSE+NSE Vol: 44.12 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
39.31
39.31
39.31
39.31
39.31
37.70
Share Warrants & Outstandings
Total Reserve
5,151.63
4,778.89
4,331.16
5,198.23
5,027.66
3,181.71
Shareholder's Funds
5,190.94
4,818.20
4,370.47
5,237.54
5,066.97
3,219.41
Minority Interest
-1.42
0.00
0.00
0.00
-60.64
-28.96
Long-Term Borrowings
0.00
0.00
0.00
0.00
199.89
886.99
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
199.89
886.99
Deferred Tax Assets / Liabilities
-166.03
-169.64
-123.01
-5.88
4.21
12.19
Other Long Term Liabilities
46.77
62.88
69.23
72.14
71.54
73.3
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
124.31
109.51
106.20
95.82
85.52
74.51
Total Non-Current Liabilities
5.05
2.75
52.42
162.08
361.16
1,046.99
Current Liabilities
Trade Payables
879.89
735.64
679.81
706.39
668.77
625.93
Other Current Liabilities
251.00
223.65
251.19
316.51
260.19
226.99
Short Term Borrowings
1,195.57
430.45
635.87
629.99
299.90
860.50
Short Term Provisions
85.87
65.25
70.06
63.64
51.99
38.19
Total Current Liabilities
2,412.33
1,454.99
1,636.93
1,716.53
1,280.85
1,751.61
Total Liabilities
7,606.90
6,275.94
6,059.82
7,116.15
6,708.98
5,989.05
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
4,117.32
3,875.19
3,467.50
2,840.34
2,545.41
2,132.42
Less: Accumulated Depreciation
1,593.79
1,328.48
1,069.05
1,042.49
756.99
580.58
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
2,523.53
2,546.71
2,398.45
1,797.85
1,788.42
1,551.84
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
837.23
524.36
601.28
2,205.79
1,944.28
1,574.10
Intangible assets under development
0.00
0.00
0.00
98.44
238.25
272.08
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
127.21
93.02
96.33
118.40
49.31
17.62
Long Term Loans & Advances
31.15
33.29
53.74
34.88
36.70
110.66
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Total Non-Current Assets
3,519.12
3,197.38
3,149.80
4,255.36
4,056.96
3,526.30
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00
186.97
0.00
Inventories
2,288.14
1,643.54
1,475.27
1,609.70
1,486.15
1,187.53
Sundry Debtors
1,399.79
1,024.84
1,046.40
807.13
348.58
864.75
Cash and Bank
90.10
126.57
82.27
69.43
105.84
80.75
Other Current Assets
80.16
94.17
138.03
76.73
95.27
59.08
Short Term Loans and Advances
229.59
189.44
168.05
297.80
429.21
270.64
Total Current Assets
4,087.78
3,078.56
2,910.02
2,860.79
2,652.02
2,462.75
Net Current Assets (Including Current Investments)
1,675.45
1,623.57
1,273.09
1,144.26
1,371.17
711.14
Total Current Assets Excluding Current Investments
4,087.78
3,078.56
2,910.02
2,860.79
2,465.05
2,462.75
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
7,606.90
6,275.94
6,059.82
7,116.15
6,708.98
5,989.05
Contingent Liabilities
68.89
54.61
109.23
62.87
100.46
117.80
Total Debt
1,195.57
430.45
635.87
629.99
499.79
1,747.49
Book Value per share (adjusted)
264.1
245.14
222.36
266.47
257.8
170.79
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2025 is 177.75% vs -32.31% in Mar 2024

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2025 is -25.62% vs -9.17% in Mar 2024

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2025 is 9.43% vs 2.38% in Mar 2024

stock-summary

Investments

YoY Growth in year ended Mar 2025 is 36.76% vs -3.44% in Mar 2024

stock-summary

Current Assets

YoY Growth in year ended Mar 2025 is 32.78% vs 5.79% in Mar 2024

Compare Balance Sheet Results of Alembic Pharma
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
39.31
20.84
18.47
88.63%
Share Warrants & Outstandings
Total Reserve
5,151.63
2,102.43
3,049.20
145.03%
Shareholder's Funds
5,190.94
2,128.35
3,062.59
143.90%
Minority Interest
-1.42
0.00
-1.42
0.00%
Long-Term Borrowings
0.00
0.00
0.00
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
-166.03
96.84
-262.87
-271.45%
Other Long Term Liabilities
46.77
164.69
-117.92
-71.60%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
124.31
23.41
100.90
431.01%
Total Non-Current Liabilities
5.05
284.93
-279.88
-98.23%
Current Liabilities
Trade Payables
879.89
322.51
557.38
172.83%
Other Current Liabilities
251.00
270.59
-19.59
-7.24%
Short Term Borrowings
1,195.57
128.64
1,066.93
829.39%
Short Term Provisions
85.87
10.76
75.11
698.05%
Total Current Liabilities
2,412.33
732.49
1,679.84
229.33%
Total Liabilities
7,606.90
3,145.78
4,461.12
141.81%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
4,117.32
1,610.23
2,507.09
155.70%
Less: Accumulated Depreciation
1,593.79
414.36
1,179.43
284.64%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
2,523.53
1,195.87
1,327.66
111.02%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
837.23
124.46
712.77
572.69%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
127.21
1.94
125.27
6,457.22%
Long Term Loans & Advances
31.15
19.57
11.58
59.17%
Other Non Current Assets
0.00
7.08
-7.08
-100.00%
Total Non-Current Assets
3,519.12
1,641.27
1,877.85
114.41%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
2,288.14
118.86
2,169.28
1,825.07%
Sundry Debtors
1,399.79
354.78
1,045.01
294.55%
Cash and Bank
90.10
463.88
-373.78
-80.58%
Other Current Assets
80.16
458.44
-378.28
-82.51%
Short Term Loans and Advances
229.59
108.54
121.05
111.53%
Total Current Assets
4,087.78
1,504.51
2,583.27
171.70%
Net Current Assets (Including Current Investments)
1,675.45
772.02
903.43
117.02%
Total Current Assets Excluding Current Investments
4,087.78
1,504.51
2,583.27
171.70%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
7,606.90
3,145.78
4,461.12
141.81%
Contingent Liabilities
68.89
58.11
10.78
18.55%
Total Debt
1,195.57
128.64
1,066.93
829.39%
Book Value per share (adjusted)
264.10
102.12
161.98
158.62%
Annual - Borrowings
Borrowings 1,195.57 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 177.75% vs -32.31% in Mar 2024

Annual - Other Long Term Liabilities
Other Long Term Liabilities 46.77 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -25.62% vs -9.17% in Mar 2024

Annual - Fixed Assets
Fixed Assets 3,360.76 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 9.43% vs 2.38% in Mar 2024

Annual - Investments
Investments 127.21 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 36.76% vs -3.44% in Mar 2024

Annual - Current Assets
Current Assets 4,087.78 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 32.78% vs 5.79% in Mar 2024